Global regulators that make up the membership of the International Coalition of Medicines Regulatory Authorities (ICMRA) will be celebrating its 10 years of strategic leadership and cooperation at the organisation’s annual summit taking place between 13-16 November, 2023 in Melbourne, Australia.

“It is important to act both locally and globally to address shared regulatory issues and challenges. Through ICMRA, we work as a global community to safeguard public health by providing strategic leadership, advancing regulatory science, sharing information and responding to crises,” Emer Cooke, the EMA’s Executive Director and chair of ICMRA.

“In the coming years, ICMRA will continue to address current and emerging human medicine regulatory and safety challenges, strengthen collaboration and communication and enhance the quality, safety and efficacy of medicines for the benefit of patients worldwide,” the EMA said in a press release.

The ICMRA, is an organisation consisting of 38 regulatory authorities that meet to provide strategic regulatory coordination. It has already made significant process in areas including antimicrobial resistance, management of medicines shortages, and coordinating response to the COVID-19 pandemic.


Further reading:

About ICMRA: